Active, not recruitingPhase 3NCT05463731
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Studying NON RARE IN EUROPE: Alzheimer disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eli Lilly and Company
- Principal Investigator
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company
- Intervention
- Remternetug (IV)(drug)
- Enrollment
- 1667 target
- Eligibility
- 60-85 years · All sexes
- Timeline
- 2022 – 2026
Study locations (30)
- MD First Research - Chandler, Chandler, Arizona, United States
- Hope Clinical Research, Inc., Canoga Park, California, United States
- North County Neurology Associates, Carlsbad, California, United States
- Wr- Pri, Llc, Encino, California, United States
- Neuro-Pain Medical Center, Fresno, California, United States
- Irvine Clinical Research, Irvine, California, United States
- Kaizen Brain Center, La Jolla, California, United States
- Anderson Clinical Research, Redlands, California, United States
- Mountain Neurological Research Center, Basalt, Colorado, United States
- Alpine Clinical Research Center, Boulder, Colorado, United States
- Colorado Springs Neurological Associates, Colorado Springs, Colorado, United States
- Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States
- Ki Health Partners, LLc, dba New England Institute for Clinical Research, Stamford, Connecticut, United States
- JEM Research Institute, Atlantis, Florida, United States
- VIN-Julie Schwartzbard, Aventura, Florida, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05463731 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Alzheimer disease
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07250113WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCTNorthwell Health
- RECRUITINGNCT07457138Lombard Cohort of Brain Health ServicesUniversity of Milano Bicocca
- RECRUITINGNANCT07286448Personalized Digital Training for COGnitive FITness in Mild Cognitive ImpairmentGiovanna Zamboni
- ACTIVE NOT RECRUITINGNANCT07479914Art of Memory for Cognitive Enhancement in the Monza Brain Health ServiceUniversity of Milano Bicocca
- RECRUITINGNANCT07212504Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory ProblemsRotman Research Institute at Baycrest
- ENROLLING BY INVITATIONNANCT07168824An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on CognitionChi-Chang Huang
- ACTIVE NOT RECRUITINGNANCT07350226Electro-acupuncture for SCD With DepressionThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- RECRUITINGNCT07402161The Signature of Alzheimer's Disease in Subjective Cognitive DeclineIRCCS Policlinico S. Donato